Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,928 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Active, Not Recruiting

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

NCT04075266

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • University of Colorado Denver Childrens Hospital Rocky Mountain MS Center Aurora, Colorado, United States
  • Childrens National Health Center Washington D.C., District of Columbia, United States
  • Boston Childrens Hospital Boston, Massachusetts, United States
  • Washington Universtiy school of Medicine St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT06180278

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Wayne State University School of Medicine Detroit, Michigan, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Prince of Wales Hospital (PWH) - The Chinese University of Hong Kong (CUHK) - Ophtalmology Hong Kong, China
  • Vseobecna fakultni nemocnice v Praze - Neurologicka klinika Prague, Czechia
View Trial Details

Related conditions